NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Panacea Venture Healthcare

Panacea Venture Healthcare

Shanghai, Shanghaipanaceaventure.com

Overview

Panacea Venture is a healthcare private equity firm led by former managing partner of Kleiner Perkins in China, James Huang, and is focused on biotech and pharmaceuticals, medical devices and diagnostics, as well as healthcare IT and services across China, the US, Europe and other major global life sciences hubs. They invest in and incubate early-stage life science companies with breakthrough technologies and discoveries that can potentially address unmet medical needs to enhance the quality of life on a global scale.

Year Founded

2017

Portfolio Companies

27

Investments

Panacea Venture Healthcare investments
CompanyDateStageLead
Kainova TherapeuticsFeb 2026Series BCo-investor
Domain TherapeuticsFeb 2026Series BCo-investor
OutSeeJan 2026SeedCo-investor
Myrtelle Inc.Dec 2025Series CCo-investor
OutSeeJun 2025GrantCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.